-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
Event / Presentation
2025.11.28
CHITOSE to Present on Mammalian Cell Technologies at JAACT 2025 in Osaka
-
CHITOSE’s AI Doubles Protein Productivity in Filamentous Fungi Compared to Best Human-Designed Conditions
-
Event / Presentation
2025.06.03
CHITOSE Presents on Novel HAT Cell Line for AAV Manufacturing at ASGCT Annual Meeting
-
CHITOSE Group, Prodezi Long An Corporation and TA Vital Join Forces to Build a Sustainable Industrial Park in Vietnam
-
CHITOSE Group Announces Capital Raising of JPY 500 Million from NSK ltd. and Conclusion of Business Alliance Agreement
-
Event / Presentation
2024.07.16
CHITOSE Presents Advanced Mammalian Cell Solutions at the 28th ESACT Meeting 2024, in Edinburgh, Scotland
-
Event / Presentation
2024.07.02
CHITOSE Attended BIO International Convention 2024
-
Starting the trial sale of organic fertilizer ‘Trichoderma fortified compost’ developed together with Sime Darby Plantation in Malaysia.
